Rommelag brings media fill case study to online Pharma Congress 2020

news-releasesRommelag

September 1st 2020

Waiblingen, Germany: – Advanced aseptic liquid filling and bottling specialist Rommelag Engineering will share advanced insights on use of Blow-Fill Seal (BFS) technology for aseptic media filling at Germany’s Pharma Congress Online in mid-September.

The annual congress, originally scheduled for Dusseldorf in March, was postponed due to the coronavirus COVID-19 crisis and will now be held as a series of online presentations on September 15-16. A further day, September 17, will be dedicated to the Pharma Technica virtual exhibition where companies will present offers, products and technologies in live online forums.

Bottelpack aseptic fill

The COVID-19 pandemic has focused new attention on the potential of BFS aseptic fill technology to help meet the challenges of producing and delivering vaccines at unprecedented scale. Rommelag bottelpack platforms able to achieve high quality and high output cGMP aseptic liquid filling of vials and ampoules to comply with FDA and EMA standards.

Dr. Martin Haerer, of Rommelag’s CMO division will contribute to the congress’s science sessions with a presentation of a case study on ‘Media Fill Design for aseptic Blow Fill Seal Filling’ that explains the general Media Fill concept, along with use of bracketing, intervention procedures and management of operator involvement and evaluation.

Innovative pharma applications

Rommelag will also use its Pharma Technica ‘virtual stand’ to showcase its latest bottelpack aseptic fill solutions and demonstrate to pharma production professionals, marketing managers, developers and plant supervisors how its Bottelpack and BFS technologies are highly applicable across a wide range of pharmaceutical and biotech applications.

These include aseptic filling, liquid filling, pharmaceutical containers, parenterals, ophthalmics, inhalations, ampoules, IV solutions and vaccines in pre-filled syringes.

About Rommelag

Rommelag Engineering sets standards in the aseptic packing of liquids and semisolids with its proprietary bottelpack® aseptic filling systems and Blow-Fill-Seal (BFS) technology.

Rommelag is the overall brand for the Group of companies that invented and developed BFS technology and has become a global market leader in the aseptic filling of liquids and semisolids with its bottelpack machines as well as film-based packaging and flexible containment solutions.

BFS technology powers a range of fully automatic bottelpack systems that can manufacture canisters, bottles, tubes, ampoules, drop bottles, bellows containers, and portion packaging in a variety of forms and plastic blends. Rommelag Engineering also supplies a range of expansion options and ancillaries including Cap-Welding Machine (SM), Ampoule Inspection System (VIM), Particle Inspection Machine (PIM) and High-Voltage Leak Detector (HVLD).

Rommelag CMO, applies BFS and bottelpack technology on behalf of clients, contract filling more than two million containers a day for customers all over the world. Rommelag CMO operates more than 50 systems in multiple configurations, set up to meet stringent pharmaceutical standards, perform test fillings, and realize production batches or small-scale series for clients.

At Rommelag Flex, is a specialist in applications for sophisticated containment solutions in the pharma industry.

Rommelag Service forms a one-stop shop for everything from consulting to spare parts to upgrades, along with expert advice from the earliest stages of process, when developing a formula or fine-tuning a product design.

About Pharmakongress 2020

The annual Pharma Congress is one of Europe’s leading forums for the pharmaceutical industry stakeholders from Europe and beyond to discuss GMP /FDA Compliance and other current industry trends while benefiting from networking opportunities.

The 2020 Pharma Congress was originally scheduled as a two-day event opening March 24 at the Crowne Plaza (former Swissôtel) in Düsseldorf but had to be postponed in the initial wave of the coronavirus COVID-19 pandemic.

The congress will now be held as a series of online presentations over two days, September 15-16. A further day, September 17, will be dedicated to the Pharma Technica virtual exhibition where companies will present offers, products and technologies in live online forums.

The online Congress will stay true to the essential ethos of “Users report for users “in providing case studies from the pharmaceutical industry that examine implementation of featured project case studies.

The congress is organized by Concept Heidelberg with further information at: https://www.pharma-kongress.de/eca-aseptic-processing.html